Crown Advisors Management, Inc. Dexcom Inc Transaction History

Crown Advisors Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $377,450 - $620,800	-5,000 Reduced 50.0%	5,000 $620,000
Q3 2023 Nov 08, 2023	BUY	$86.06 - $137.93 $860,600 - $1.38 Million	10,000 New	10,000 $933,000
Q4 2020 Feb 09, 2021	SELL	$78.0 - $104.5 $468,000 - $627,000	-6,000 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$95.51 - $112.95 $191,020 - $225,900	-2,000 Reduced 25.0%	6,000 $2.47 Million
Q2 2020 Aug 06, 2020	BUY	$62.68 - $105.34 $501,440 - $842,720	8,000 New	8,000 $3.24 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Crown Advisors Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Crown Advisors Management, Inc. with notifications on news.